Soy inclusion in the diet improves features of the metabolic syndrome: A randomized crossover study in postmenopausal women

American Journal of Clinical Nutrition

Volumn 85, Issue 3, 2007, Pages 735-741

  Azadbakht, Leila ^a   Kimiagar, Masoud ^a   Mehrabi, Yadollah ^b   Esmaillzadeh, Ahmad ^a   Padyab, Mojgan ^b   Hu, Frank B ^c   Willett, Walter C ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Glycemic control; Insulin resistance; Lipid profiles; Metabolic syndrome; Soy

Indexed keywords

LIPID; LIPOPROTEIN; SOYBEAN PROTEIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FOOD COMPOSITION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; POSTMENOPAUSE; PROTEIN DIET; RANDOMIZED CONTROLLED TRIAL;

EID: 33847772975     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.3.735     Document Type: Article

References (53)

1. Lau DC, Yan H, Dhillon B. Metabolic syndrome: a marker of patients at high cardiovascular risk. Can J Cardiol 2006;22:85B-90B.
2. Das UN. Is metabolic syndrome X an inflammatory condition? Exp Biol Med 2002;227:989-97.
3. Cankurtaran M, Halil M, Yavuz BB, Dagli N, Oyan B, Ariogul S. Prevalence and correlates of metabolic syndrome (MS) in older adults. Arch Gerondol Geriatr 2006;42:35-45.
4. Ford ES, GilesWH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004;27:2444-9.
5. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003;61:29-37.
6. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
7. Hollenberg NK. Genetic versus environmental etiology of the metabolic syndrome among male and female twins. Curr Hypertens Rep 2002;4:178.
8. Vessby B. Dietary fat and insulin action in humans. Br J Nutr 2000;83:591-6.
9. Connor W. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 2000;47:419-25.
10. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F. Dairy consumption is favorably associated with metabolic syndrom in Tehranian adults. Am J Clin Nutr 2005;82:523-30.
11. Esmaillzadeh A, Mirmiran P, Azizi F. Whole-grain intake and the prevalence of hypertriglyceridemic waist phenotype in Tehranian adults. Am J Clin Nutr 2005;81:55-63.
12. Esposito K, Marfella R, Citotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trail. JAMA 2004;292:1440-6.
13. Riccardi G, Rivellese AA. Dietary treatment of the metabolic syndrome-the optimal diet. Br J Nutr 2000;83:S143-8.
14. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approach to Stop Hypertension (DASH) eating plan on features of metabolic syndrome. Diabetes Care 2005;28:2823-31.
15. Klimes I, Sebokova E. The importance of diet therapy in the prevention and treatment of manifestations of metabolic syndrome X. Vnitr Lek 1995;41:136-40 (abstract).
16. Jayagopal V, Albertazzi P, Kilpatrick ES, et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 2002;25:1709-14.
17. Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y, Esmaill-Zadeh A. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 2003;57:1292-4.
18. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-82.
19. Anderson JW, Blake JE, Turner J, Smith BM. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr 1998;68(suppl):1347S-53S.
20. McVeigh BL, Dillingham BL, Lampe JW, Duncan AM. Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. Am J Clin Nutr 2006;83:244-51.
21. Davis J, Iqbal MJ, Steinle J, et al. Soy protein influences the development of the metabolic syndrome in male obese ZDFxSHHF rats. Horm Metab Res 2005;37:316-25.
22. Dyrskog SE, Jeppesen PB, Colombo M, Abudula R, Hermansen K. Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats. Metabolism 2005;54:1181-8.
23. Wangen KE, Duncan AM, Xu X, Kurzer MS. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 2001;73:225-31.
24. Merz-Demlow BE, Duncan AM, Wangen KE, et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr 2000;1:1462-9.
25. Jenkins DJ, Kendall CW, Jackson CJ, et al. Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 2002;76:365-72.
26. Kim JI, Kim JC, Kang MJ, Lee MS, Kim JJ, Cha IJ. Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study. Eur J Clin Nutr 2005;59:456-8.
27. Crisafulli A, Altavilla D, Marini H, et al. Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women. Menopause 2005;12:186-92.
28. von Post-Skagegard M, Vessby B, Karlstrom B. Glucose and insulin responses in healthy women after intake of composite meals containing cod-, milk-, and soy protein. Eur J Clin Nutr 2006 Feb 15. Epub ahead of print.
29. Rozenberg S, Bosson D, Peretz A, Caufriez A, Robyn C. Serum levels of gonadotrophins and steroid hormones in the post-menopause and later life. Maturitas 1988;10:215-24.
30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
31. Karanja NM, Obarzanek E, Lin PH, et al. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension trial. J Am Diet Assoc 1999;99:S60-8.
32. Mahan LK, Escott-stump S. Krauses food nutrition and diet therapy. 11th ed. Philadelphia, PA: WB Saunders, 2004:1267-8.
33. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intake for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, DC: The National Academies Press, 2002.
34. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-95.
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
36. Welborn TA, Garcia-Webb P, Bonser AM. Basal C-peptide in the discrimination of type I from type II diabetes. Diabetes Care 1981;4:616-9.
37. Franke AA, Custer LJ, Tanaka Y. Isoflavones in human breast milk and other biological fluids. Am J Clin Nutr 1998;8(suppl):1466S-73S.
38. Franke AA, Custer LJ, Wang W, Shi CY. HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 1998;217:263-73.
39. Hoie LH, Graubaum HJ, Harde A, Gruenwald J, Wernecke KD. Lipid-lowering effect of 2 dosages of a soy protein supplement in hypercholesterolemia. Adv Ther 2005;22:175-86.
40. Hermansen K, Hansen B, Jacobsen R, et al. Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects. Eur J Clin Nutr 2005;59:843-50.
41. Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 2005;81:397-408.
42. Zhuo XG, Melby MK, Watanabe S. Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans. J Nutr 2004;134:2395-400.
43. Hodgson JM, Puddey IB, Beilin LJ, et al. Effects of isoflavonoids on blood pressure in subjects with high-normal ambulatory blood pressure levels: a randomized controlled trial. Am J Hypertens 1999;12:47-53.
44. Hermansen K, Sondergaard M, Hoie L, Carstensen M, Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 2001;24:228-33.
45. Kris-Etherton PM, West SG. Soy protein with or without isoflavones: in search of a cardioprotective mechanism of action. Am J Clin Nutr 2005;81:5-6.
46. Zhang X, Shu XO, Gao YT, et al. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 2003;133:2874-8.
47. Barnes S, Peterson TG, Coward L. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem 1995(suppl);22:181-7.
48. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M, American Heart Association Nutrition Committee. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006;113:1034-44.
49. Vergroes AJ. Dietary fat and cardiovascular disease: possible modes of action of linoleic acid. Proc Nutr sac 1972;31:323-9.
50. Willett WC, Skerrett PK. Eat, drink and be healthy. The Harvard Medical School Guide to healthy eating. New York, NY: Simon and Schuster Inc, 2005:130-1.
51. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavon. J Nutr 2002;132:3577-84.
52. Kreijkamp-Kaspers S, Kok L, Bots ML, Grobbee DE, Lampe JW, van der Schouw YT. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am J Clin Nutr 2005;81:189-95.
53. Hall WL, Vafeiadou K, Hallund J, et al. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 2006;83:592-600.